Home › Geographic Atrophy › New York
Geographic Atrophy clinical trials in New York
4 studies for Geographic Atrophy are looking for participants at sites in New York.
Cities in New York
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina-Vitreous Surgeons of Central New York, Liverpool
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- Long Island and Queens Vitreoretinal Consultants of NY, P.C., Hauppauge
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Sight MD, Brentwood
- Retina Vitreous Surgeons of Central New York, PC, Liverpool
- New York Ear & Eye- East 85th, New York
- and 3 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Vitreous Surgeons of CNY, PC, Liverpool
- Ophthalmic Consultants of Long Island, Oceanside
- Retina Associates of Western NY, Rochester
- and 1 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.